| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1016761177 |
| P356 | DOI | 10.1186/1471-2180-11-97 |
| P932 | PMC publication ID | 3119188 |
| P698 | PubMed publication ID | 21569340 |
| P5875 | ResearchGate publication ID | 51123927 |
| P50 | author | Maurizio Sanguinetti | Q38325512 |
| Dominique Sanglard | Q40141436 | ||
| Brunella Posteraro | Q41881644 | ||
| Riccardo Torelli | Q56285785 | ||
| Elena De Carolis | Q57097045 | ||
| Ada Rita Florio | Q114423952 | ||
| P2093 | author name string | Giovanni Fadda | |
| Selene Ferrari | |||
| P2860 | cites work | The genome of the basidiomycetous yeast and human pathogen Cryptococcus neoformans | Q22065807 |
| Cryptococcus neoformans overcomes stress of azole drugs by formation of disomy in specific multiple chromosomes | Q27315103 | ||
| Involvement of yeast YOL151W/GRE2 in ergosterol metabolism | Q27930740 | ||
| Identification of a novel system for boron transport: Atr1 is a main boron exporter in yeast. | Q27937700 | ||
| Combined phylogeny and neighborhood analysis of the evolution of the ABC transporters conferring multiple drug resistance in hemiascomycete yeasts | Q27939331 | ||
| Upregulation of ERG genes in Candida species by azoles and other sterol biosynthesis inhibitors | Q28344744 | ||
| A link between virulence and homeostatic responses to hypoxia during infection by the human fungal pathogen Cryptococcus neoformans | Q28469145 | ||
| Protein sensors for membrane sterols | Q29617313 | ||
| Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS | Q29617372 | ||
| Identification and characterization of a Cryptococcus neoformans ATP binding cassette (ABC) transporter-encoding gene, CnAFR1, involved in the resistance to fluconazole | Q30879441 | ||
| Molecular characterization of the plasma membrane H(+)-ATPase, an antifungal target in Cryptococcus neoformans | Q30908894 | ||
| Gene expression omnibus: microarray data storage, submission, retrieval, and analysis | Q31057685 | ||
| Efflux in fungi: la pièce de résistance | Q33474798 | ||
| Cas3p belongs to a seven-member family of capsule structure designer proteins | Q33560210 | ||
| Sterol regulatory element binding proteins in fungi: hypoxic transcription factors linked to pathogenesis | Q33725227 | ||
| Mechanism of the synergistic effect of amiodarone and fluconazole in Candida albicans | Q33826488 | ||
| How sweet it is! Cell wall biogenesis and polysaccharide capsule formation in Cryptococcus neoformans | Q33894565 | ||
| Heteroresistance to fluconazole and voriconazole in Cryptococcus neoformans | Q33977302 | ||
| Cryptococcus neoformans Site-2 protease is required for virulence and survival in the presence of azole drugs | Q34048162 | ||
| Comparative transcriptome analysis of the CO2 sensing pathway via differential expression of carbonic anhydrase in Cryptococcus neoformans | Q34082194 | ||
| Role of AFR1, an ABC transporter-encoding gene, in the in vivo response to fluconazole and virulence of Cryptococcus neoformans | Q34334162 | ||
| Molecular basis of resistance to azole antifungals | Q34508503 | ||
| Chitosan, the deacetylated form of chitin, is necessary for cell wall integrity in Cryptococcus neoformans. | Q35855079 | ||
| Complementation of a capsule-deficient mutation of Cryptococcus neoformans restores its virulence | Q36657718 | ||
| Cryptococcus neoformans, a fungus under stress | Q36914008 | ||
| Efflux-mediated antifungal drug resistance. | Q37156645 | ||
| Heteroresistance to fluconazole in Cryptococcus neoformans is intrinsic and associated with virulence | Q37247728 | ||
| Remodeling of global transcription patterns of Cryptococcus neoformans genes mediated by the stress-activated HOG signaling pathways | Q37301922 | ||
| Drug:H+ antiporters in chemical stress response in yeast | Q37343243 | ||
| Conservation of the sterol regulatory element-binding protein pathway and its pathobiological importance in Cryptococcus neoformans | Q37410081 | ||
| Identification of Cryptococcus neoformans temperature-regulated genes with a genomic-DNA microarray | Q37579804 | ||
| Genomic profiling of the response of Candida albicans to itraconazole treatment using a DNA microarray | Q38300837 | ||
| Sre1p, a regulator of oxygen sensing and sterol homeostasis, is required for virulence in Cryptococcus neoformans | Q38302324 | ||
| Comparison of gene expression profiles of Candida albicans azole-resistant clinical isolates and laboratory strains exposed to drugs inducing multidrug transporters | Q38338527 | ||
| Genome-wide expression patterns in Saccharomyces cerevisiae: comparison of drug treatments and genetic alterations affecting biosynthesis of ergosterol | Q39473756 | ||
| Fluconazole at subinhibitory concentrations induces the oxidative- and nitrosative-responsive genes TRR1, GRE2 and YHB1, and enhances the resistance of Candida albicans to phagocytes | Q39777653 | ||
| Biochemical targets for antifungal azole derivatives: hypothesis on the mode of action. | Q39844899 | ||
| Lipid signaling in pathogenic fungi | Q39978770 | ||
| Cell wall integrity is dependent on the PKC1 signal transduction pathway in Cryptococcus neoformans. | Q40384960 | ||
| Fungal echinocandin resistance. | Q41848811 | ||
| Fluconazole and itraconazole susceptibility of clinical isolates of Cryptococcus neoformans at a tertiary care centre in India: a need for care | Q44570712 | ||
| Enzymes that Counteract Nitrosative Stress Promote Fungal Virulence | Q44653973 | ||
| Increasing in vitro resistance to fluconazole in Cryptococcus neoformans Cambodian isolates: April 2000 to March 2002. | Q44978557 | ||
| Antifungal drug susceptibility of Cryptococcus neoformans from clinical sources in Nairobi, Kenya | Q46421581 | ||
| Cell wall-linked cryptococcal phospholipase B1 is a source of secreted enzyme and a determinant of cell wall integrity | Q46942417 | ||
| Drug resistance in Cryptococcus neoformans. | Q53998982 | ||
| Cryptococcal meningitis. | Q54075694 | ||
| The Hsp70 member, Ssa1, acts as a DNA-binding transcriptional co-activator of laccase in Cryptococcus neoformans | Q62638331 | ||
| Decreased virulence in stable, acapsular mutants of cryptococcus neoformans | Q71441160 | ||
| Cryptococcosis | Q78746513 | ||
| Fungal infections in solid organ transplantation | Q80353064 | ||
| Prevalence of HIV-associated cryptococcal meningitis and utility of microbiological determinants for its diagnosis in a tertiary care center | Q81586120 | ||
| New insights on the pathogenesis of invasive Cryptococcus neoformans infection | Q81593297 | ||
| P921 | main subject | Cryptococcus neoformans | Q131924 |
| fluconazole | Q411478 | ||
| P304 | page(s) | 97 | |
| P577 | publication date | 2011-05-11 | |
| P1433 | published in | BMC Microbiology | Q15759430 |
| P1476 | title | Genome-wide expression profiling of the response to short-term exposure to fluconazole in Cryptococcus neoformans serotype A | |
| P478 | volume | 11 |
| Q35319616 | 9-O-butyl-13-(4-isopropylbenzyl)berberine, KR-72, is a potent antifungal agent that inhibits the growth of Cryptococcus neoformans by regulating gene expression |
| Q36445833 | A defect in iron uptake enhances the susceptibility of Cryptococcus neoformans to azole antifungal drugs. |
| Q49537989 | Abnormal Ergosterol Biosynthesis Activates Transcriptional Responses to Antifungal Azoles. |
| Q91686097 | Antiphagocytic protein 1 increases the susceptibility of Cryptococcus neoformans to amphotericin B and fluconazole |
| Q52935267 | Azoles activate Atf1-mediated transcription through MAP kinase pathway for antifungal effects in fission yeast. |
| Q27025924 | Cryptococcus neoformans: historical curiosity to modern pathogen |
| Q54978161 | Evolutionarily Conserved and Divergent Roles of Unfolded Protein Response (UPR) in the Pathogenic Cryptococcus Species Complex. |
| Q37126219 | Fungal cell wall dynamics and infection site microenvironments: signal integration and infection outcome |
| Q40103625 | Heat shock protein 90 localizes to the surface and augments virulence factors of Cryptococcus neoformans. |
| Q28483330 | Identification and characterization of antifungal compounds using a Saccharomyces cerevisiae reporter bioassay |
| Q89048076 | Identifying a novel connection between the fungal plasma membrane and pH-sensing |
| Q46458243 | Multilocus resistance evolution to azole fungicides in fungal plant pathogen populations. |
| Q35148713 | Network-assisted genetic dissection of pathogenicity and drug resistance in the opportunistic human pathogenic fungus Cryptococcus neoformans |
| Q35611515 | New technology and resources for cryptococcal research |
| Q33813958 | RNA biology and the adaptation of Cryptococcus neoformans to host temperature and stress |
| Q49598890 | Role of three Cryptococcus neoformans and C. gattii efflux pump coding genes in response to drug treatment. |
| Q36882388 | Sterol C-22 Desaturase ERG5 Mediates the Sensitivity to Antifungal Azoles in Neurospora crassa and Fusarium verticillioides |
| Q34960987 | Ten challenges on Cryptococcus and cryptococcosis |
| Q28482096 | Time-course proteome analysis reveals the dynamic response of Cryptococcus gattii cells to fluconazole |
| Q41652452 | Unraveling the biology of a fungal meningitis pathogen using chemical genetics |
Search more.